AstraZeneca (AZN) - Research Analysts' Recent Ratings Changes


They now have a "buy" rating on the stock. 3/20/2018 - AstraZeneca was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.



from Biotech News